机译:对慢性髓性白血病(CML)的新型高效和选择性II天然和耐药V299L突变体BCR-ABL-039)的发现和表征
Chinese Acad Sci High Magnet Field Lab 350 Shushanhu Rd Mailbox 1110 Hefei 230031 Anhui;
Chinese Acad Sci High Magnet Field Lab 350 Shushanhu Rd Mailbox 1110 Hefei 230031 Anhui;
Chinese Acad Sci High Magnet Field Lab 350 Shushanhu Rd Mailbox 1110 Hefei 230031 Anhui;
Chinese Acad Sci High Magnet Field Lab 350 Shushanhu Rd Mailbox 1110 Hefei 230031 Anhui;
Chinese Acad Sci High Magnet Field Lab 350 Shushanhu Rd Mailbox 1110 Hefei 230031 Anhui;
Chinese Acad Sci High Magnet Field Lab 350 Shushanhu Rd Mailbox 1110 Hefei 230031 Anhui;
Chinese Acad Sci High Magnet Field Lab 350 Shushanhu Rd Mailbox 1110 Hefei 230031 Anhui;
Chinese Acad Sci High Magnet Field Lab 350 Shushanhu Rd Mailbox 1110 Hefei 230031 Anhui;
Chinese Acad Sci Hefei Inst Phys Sci Inst Technol Innovat Precis Targeted Therapy Discovery Ctr;
Chinese Acad Sci Hefei Inst Phys Sci Inst Technol Innovat Precis Targeted Therapy Discovery Ctr;
Chinese Acad Sci High Magnet Field Lab 350 Shushanhu Rd Mailbox 1110 Hefei 230031 Anhui;
Chinese Acad Sci High Magnet Field Lab 350 Shushanhu Rd Mailbox 1110 Hefei 230031 Anhui;
Chinese Acad Sci Hefei Inst Phys Sci Inst Technol Innovat Precis Targeted Therapy Discovery Ctr;
Chinese Acad Sci High Magnet Field Lab 350 Shushanhu Rd Mailbox 1110 Hefei 230031 Anhui;
Chinese Acad Sci High Magnet Field Lab 350 Shushanhu Rd Mailbox 1110 Hefei 230031 Anhui;
Anhui Med Univ Dept Hematol Hosp 1 Hefei Anhui Peoples R China;
Anhui Med Univ Dept Hematol Hosp 1 Hefei Anhui Peoples R China;
Chinese Acad Sci Hefei Inst Phys Sci Inst Technol Innovat Precis Targeted Therapy Discovery Ctr;
Anhui Med Univ Dept Hematol Hosp 1 Hefei Anhui Peoples R China;
Chinese Acad Sci High Magnet Field Lab 350 Shushanhu Rd Mailbox 1110 Hefei 230031 Anhui;
BCR-ABL; PDGFR; chronic myeloid leukemia; kinase inhibitor;
机译:对慢性髓性白血病(CML)的新型高效和选择性II天然和耐药V299L突变体BCR-ABL-039)的发现和表征
机译:2-((3-氨基-4-甲基苯基)氨基)-N-(2-甲基-5-(3-(三氟甲基)苯甲酰胺基)苯基)-4-(甲基氨基)嘧啶-5-羧酰胺(CHMFL- ABL-053)作为慢性粒细胞白血病的有效,选择性和口服BCR-ABL / SRC / p38激酶抑制剂
机译:BCR-ABL酪氨酸激酶特异性抑制剂在慢性粒细胞白血病中的功效和安全性BCR-ABL酪氨酸激酶特异性抑制剂在慢性粒细胞白血病和急性淋巴细胞白血病机智的爆发危机中的活性
机译:慢性骨髓白血病(CML)的临床抗性BCR-ABL突变体的绝对量化
机译:人类免疫缺陷病毒(HIV)I型整合酶抑制剂结合口袋的表征和新型抗HIV药物耐药变体的抑制剂的发现
机译:发现和表征一种新型的强效和选择性II型天然和耐药V299L突变型BCR-ABL抑制剂(CHMFL-ABL-039)用于治疗慢性粒细胞白血病(CML)
机译:用于慢性髓性白血病(CML)的新型有效型II天然和突变体BCR-ABL抑制剂(CHMFL-074)的发现和表征